Do you know the latest ACIP guidelines on pneumococcal vaccination? Take this short quiz to "show you know" about new serotype coverage, dosing intervals, workflow integration, addressing vaccine hesitancy, and administration of appropriate pneumococcal vaccines to eligible patients to protect communities from vaccine-preventable disease.
Supported by
BF is a 69-year-old male patient who presents to the pharmacy asking about pneumococcal vaccination. He states he received one dose of PPSV23 (23-valent pneumococcal polysaccharide vaccine) when he was 65 years old and was wondering whether he needed another dose. He tells you that is the only pneumococcal vaccination he has ever received.
